Published in J Clin Pathol on February 01, 1998
Comparative evaluation of semiautomated COBAS AMPLICOR hepatitis B virus (HBV) monitor test and manual microwell plate-based AMPLICOR HBV MONITOR test. J Clin Microbiol (2001) 1.04
Fully automated, internally controlled quantification of hepatitis B Virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments. J Clin Microbiol (2004) 1.00
Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan. J Clin Pathol (2004) 0.84
LNA real-time PCR probe quantification of hepatitis B virus DNA. Exp Ther Med (2011) 0.80
The polymerase chain reaction--a time of transition from research to routine. J Clin Pathol (1998) 0.79
Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation? Dig Dis Sci (2002) 0.75
Vaccine-induced escape mutant of hepatitis B virus. Lancet (1990) 5.31
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet (1995) 2.82
Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol (1994) 2.05
Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest (1992) 1.48
Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication. J Clin Invest (1996) 1.48
Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology (1992) 1.37
Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion (1995) 1.33
Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci U S A (1996) 1.32
Antigenic structure of hepatitis B surface antigen: identification of the "d" subtype determinant by chemical modification and use of monoclonal antibodies. J Immunol (1984) 1.21
The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology (1997) 1.15
A unique insertion in the S gene of surface antigen--negative hepatitis B virus Chinese carriers. Hepatology (1995) 1.14
Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr Res (1992) 1.11
Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun (1992) 1.05
Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol (1996) 1.00
Hepatitis B virus: significance of naturally occurring mutants. Intervirology (1993) 0.94
Viral genetic variation: hepatitis B virus as a clinical example. Lancet (1993) 0.93
Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier. Dig Dis Sci (1995) 0.88
Precore and X region mutants in hepatitis B virus infections among renal dialysis patients. J Viral Hepat (1995) 0.80
Amplification and sequence analysis of the precore and core region of the HBV genome from sera of Spanish patients with HBV2-like infections. J Med Virol (1995) 0.80
Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet (2000) 5.77
Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med (1994) 4.09
Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis (1997) 3.39
HCV confirmatory testing of blood donors. Lancet (1991) 3.29
Testing of blood donations for hepatitis C virus. Lancet (1994) 3.27
Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region. J Gen Virol (1995) 3.10
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol (1994) 2.90
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology (2001) 2.62
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology (1998) 2.62
The TEAM (Total Exposure Assessment Methodology) Study: personal exposures to toxic substances in air, drinking water, and breath of 400 residents of New Jersey, North Carolina, and North Dakota. Environ Res (1987) 2.53
A cumulative review of studies on travellers, their experience of illness and the implications of these findings. J Infect (1990) 2.50
Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3. J Clin Microbiol (1993) 2.36
Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology (2001) 2.30
Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities. Transfusion (1993) 2.24
Frequent presence of HBV in the sera of HBsAg-negative, anti-HBc-positive blood donors. Transfusion (2001) 2.16
Intra- and interrater variation in the evaluation of videofluorographic swallowing studies. Dysphagia (1998) 2.07
Real-time RT-PCR detection of 12 respiratory viral infections in four triplex reactions. J Clin Virol (2005) 1.86
An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS (1989) 1.80
Personal air exposures and breath concentrations of benzene and other volatile hydrocarbons for smokers and nonsmokers. Toxicol Lett (1987) 1.69
Particle Total Exposure Assessment Methodology (PTEAM) study: distributions of aerosol and elemental concentrations in personal, indoor, and outdoor air samples in a southern California community. J Expo Anal Environ Epidemiol (1993) 1.67
Personal exposure to volatile organic compounds. I. Direct measurements in breathing-zone air, drinking water, food, and exhaled breath. Environ Res (1984) 1.67
Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J (2000) 1.66
Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology (Oxford) (2001) 1.56
Treatment of chronic hepatitis B virus infection: an Asia-Pacific perspective. J Gastroenterol Hepatol (1999) 1.54
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfus Med (1994) 1.51
Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study. Hepatology (2000) 1.50
Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect (2002) 1.49
Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol (1998) 1.47
Association between secretor status and respiratory viral illness. BMJ (1991) 1.47
Blood-donors with history of jaundice. Lancet (1979) 1.45
Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sang (2005) 1.45
Child and adolescent mental health service use. HoNOSCA as an outcome measure. Br J Psychiatry (2000) 1.45
Controlled comparison of the characteristics of long-term benzodiazepine users in general practice. Br J Gen Pract (1990) 1.42
BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen. Transpl Infect Dis (2010) 1.40
Response to interferon-alpha 2a in patients with e antigen-negative chronic hepatitis B. J Clin Gastroenterol (1997) 1.40
Evidence for Chlamydia pneumoniae of non-human origin. J Gen Microbiol (1993) 1.40
Determinants of universal adolescent hepatitis B vaccine uptake. Arch Dis Child (2004) 1.37
Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ (2002) 1.37
Occurrence of haemagglutinin mutation D222G in pandemic influenza A(H1N1) infected patients in the West of Scotland, United Kingdom, 2009-10. Euro Surveill (2010) 1.34
Rapid virological surveillance of community influenza infection in general practice. BMJ (2000) 1.31
Mapping the quality of life and unmet needs of urban women with metastatic breast cancer. Eur J Cancer Care (Engl) (2005) 1.30
Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene (2009) 1.29
The effect of surgical approach on blood flow to the femoral head during resurfacing. J Bone Joint Surg Br (2007) 1.28
The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res (1998) 1.26
BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry (2005) 1.22
A comparison of virus isolation, indirect immunofluorescence and nested multiplex polymerase chain reaction for the diagnosis of primary and recurrent herpes simplex type 1 and type 2 infections. J Virol Methods (1999) 1.22
Re-evaluation of monocular cataracts in children. Am J Ophthalmol (1973) 1.22
Particle Total Exposure Assessment Methodology (PTEAM) 1990 study: method performance and data quality for personal, indoor, and outdoor monitoring. J Expo Anal Environ Epidemiol (1993) 1.22
Costs of running a universal adolescent hepatitis B vaccination programme. Vaccine (2005) 1.21
Practical experience of high throughput real time PCR in the routine diagnostic virology setting. J Clin Virol (2006) 1.21
Barriers to effective cancer pain management: a survey of Australian family caregivers. Eur J Cancer Care (Engl) (2004) 1.19
Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver. Hepatology (1999) 1.19
Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect (1999) 1.18
Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology (2000) 1.16
Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. Arch Virol (1999) 1.16
Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin. J Viral Hepat (2009) 1.14
Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK). Bull World Health Organ (1987) 1.13
2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill (2010) 1.13
Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate. Biochem J (1970) 1.13
Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care. Br J Gen Pract (1990) 1.12
A study of postdiagnosis breast cancer concerns for women living in rural and remote Queensland. Part II: Support issues. Aust J Rural Health (1999) 1.11
HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. J Viral Hepat (2004) 1.11
Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine (2004) 1.10
The contribution of traffic to indoor concentrations of polycyclic aromatic hydrocarbons. J Expo Anal Environ Epidemiol (1999) 1.09
The development of Chlamydia trachomatis inclusions within the host eukaryotic cell during interphase and mitosis. J Gen Microbiol (1989) 1.09
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology (1992) 1.08
Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study. Dig Dis Sci (1993) 1.08
Effect of some inhibitors of platelet aggregation on platelet nucleotides. Biochem J (1969) 1.08
Effect of water temperature on dermal exposure to chloroform. Environ Health Perspect (1998) 1.07
Nosocomial transmission of influenza. Occup Med (Lond) (2002) 1.07
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death. J Viral Hepat (2004) 1.06
Improved speed and accuracy of calculations with a programmable calculator in pediatric emergency scenarios. Am J Dis Child (1991) 1.06
Molecular epidemiology of syphilis in Scotland. Sex Transm Infect (2009) 1.04
T1762/A1764 variants of the basal core promoter of hepatitis B virus; serological and clinical correlations in Chinese patients. Liver (1999) 1.04
Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J Clin Invest (1997) 1.03
Intracerebral microaneurysms and small cerebrovascular lesions. Brain (1967) 1.03
HBsAg detection--results of comparative large scale testing of blood donations. Med Lab Sci (1979) 1.02
Equilibrium folding of dimeric class mu glutathione transferases involves a stable monomeric intermediate. Biochemistry (2000) 1.02
HCV confirmatory testing of blood donors. Lancet (1992) 1.02
The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology (1992) 1.02
Sildenafil: study of a novel oral treatment for erectile dysfunction in diabetic men. Diabet Med (1998) 1.01
Duration of viremia in human hepatitis A viral infection as determined by polymerase chain reaction. J Med Virol (1993) 0.99
Hepatitis B virus precore/core variation and interferon therapy. Hepatology (1995) 0.99
Norwalk like virus by light cycler PCR. J Clin Virol (2002) 0.99
Molecular cloning of the second major allergen, Cry j II, from Japanese cedar pollen. FEBS Lett (1994) 0.98
Serological response to influenza vaccination and nutritional and functional status of patients in geriatric medical long-term care. Age Ageing (1999) 0.98
Body burden measurements and models to assess inhalation exposure to methyl tertiary butyl ether (MTBE). J Air Waste Manag Assoc (1997) 0.98
Using multiplex real time PCR in order to streamline a routine diagnostic service. J Clin Virol (2008) 0.98
High detection frequency and viral loads of human rhinovirus species A to C in fecal samples; diagnostic and clinical implications. J Med Virol (2012) 0.98
A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses. J Clin Virol (2005) 0.97
Rotavirus gastroenteritis and central nervous system (CNS) infection: characterization of the VP7 and VP4 genes of rotavirus strains isolated from paired fecal and cerebrospinal fluid samples from a child with CNS disease. J Clin Microbiol (2002) 0.97
Meeting the support and information needs of women with advanced breast cancer: a randomised controlled trial. Br J Cancer (2006) 0.97
The pharmacokinetics of pulmonary-delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit. Pharm Res (1992) 0.96
Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods (2009) 0.96
Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol (1991) 0.95
Influence of viraemia and genotype upon serological reactivity in screening assays for antibody to hepatitis C virus. J Med Virol (1996) 0.95